Recombinant Human NXPH1 protein (His tag)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human NXPH1 protein (His tag) is a Human Full Length protein, in the 22 to 271 aa range, expressed in Baculovirus infected insect cells, with >90%, < 1 EU/µg endotoxin level, suitable for SDS-PAGE.
View Alternative Names
NPH1, Nbla00697, NXPH1, Neurexophilin-1
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human NXPH1 protein (His tag) (AB222981)
15% SDS-PAGE analysis of 3 μg ab222981.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Neurexophilin-1 participates in neuronal communication and acts as part of a complex with neurexins. By binding to neurexins NXPH1 influences the organization of synaptic junctions facilitating signaling between neurons. These interactions are critical for processes such as learning and memory as they support the maintenance and regulation of synaptic connections.
Pathways
NXPH1 significantly contributes to the regulation of neurotransmission and synaptic signaling. In the glutamatergic synaptic pathway NXPH1 interacts with neurexins to facilitate the release of glutamate an important neurotransmitter. Additionally it may play a role in the dopaminergic synaptic pathways by influencing dopamine receptor connectivity with proteins like neuroligins.
Specifications
Form
Liquid
Additional notes
Affinity purified
General info
Function
May be signaling molecules that resemble neuropeptides and that act by binding to alpha-neurexins and possibly other receptors.
Sequence similarities
Belongs to the neurexophilin family.
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com